This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
BVX Overzicht aandelen
A biotechnology company, engages in the research and experimental development of pharmaceutical products in the United Kingdom.
| Sneeuwvlok Score | |
|---|---|
| Waardering | 1/6 |
| Toekomstige groei | 0/6 |
| Prestaties in het verleden | 0/6 |
| Financiële gezondheid | 4/6 |
| Dividenden | 0/6 |
BiVictriX Therapeutics plc Concurrenten
Prijsgeschiedenis en prestaties
| Historische aandelenkoersen | |
|---|---|
| Huidige aandelenkoers | UK£0.10 |
| 52 Week Hoogtepunt | UK£0.14 |
| 52 Week Laag | UK£0.07 |
| Bèta | -0.73 |
| 11 maand verandering | -23.08% |
| 3 maanden verandering | -18.37% |
| 1 Jaar Verandering | -28.57% |
| 33 jaar verandering | -50.00% |
| 5 jaar verandering | n/a |
| Verandering sinds IPO | -60.78% |
Recent nieuws en updates
Recent updates
Rendement voor aandeelhouders
| BVX | GB Biotechs | GB Markt | |
|---|---|---|---|
| 7D | 33.3% | 1.2% | 1.1% |
| 1Y | -28.6% | -13.5% | 11.5% |
Rendement versus industrie: BVX underperformed the UK Biotechs industry which returned -21.4% over the past year.
Rendement versus markt: BVX underperformed the UK Market which returned 8.3% over the past year.
Prijsvolatiliteit
| BVX volatility | |
|---|---|
| BVX Average Weekly Movement | 13.0% |
| Biotechs Industry Average Movement | 8.5% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in GB Market | 9.3% |
| 10% least volatile stocks in GB Market | 2.6% |
Stabiele aandelenkoers: BVX's share price has been volatile over the past 3 months.
Volatiliteit in de loop van de tijd: BVX's weekly volatility has increased from 7% to 13% over the past year.
Over het bedrijf
| Opgericht | Werknemers | CEO | Website |
|---|---|---|---|
| 2016 | 17 | Tiffany Thorn | www.bivictrix.com |
BiVictriX Therapeutics plc Samenvatting
| BVX fundamentele statistieken | |
|---|---|
| Marktkapitalisatie | UK£8.25m |
| Inkomsten(TTM) | -UK£2.67m |
| Inkomsten(TTM) | n/a |
0.0x
P/S-verhouding-3.1x
Koers/WinstverhoudingIs BVX overgewaardeerd?
Zie Reële waarde en waarderingsanalyseInkomsten en omzet
| BVX resultatenrekening (TTM) | |
|---|---|
| Inkomsten | UK£0 |
| Kosten van inkomsten | UK£0 |
| Brutowinst | UK£0 |
| Overige uitgaven | UK£2.67m |
| Inkomsten | -UK£2.67m |
Laatst gerapporteerde inkomsten
Jun 30, 2024
Volgende inkomensdatum
n.v.t.
| Winst per aandeel (EPS) | -0.032 |
| Brutomarge | 0.00% |
| Nettowinstmarge | 0.00% |
| Schuld/Eigen Vermogen Verhouding | 0% |
Hoe presteerde BVX op de lange termijn?
Bekijk historische prestaties en vergelijking